Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline

Latigo Biotherapeutics, backed by Blue Owl, filed for an IPO.

The biotech firm is joining a growing pipeline of companies planning to go public.

The IPO is expected to occur as soon as this quarter.